NJAOPS MEMBERSHIP APPRECIATION EVENT
Wednesday, September 22nd, 2021
Treatment Strategies in PAH: Recent and Emerging Research
Kerri Akaya Smith, MD
Assistant Professor, Medical Director of Pulmonary Hypertension
Penn Medicine UPHS
Assistant Professor of Clinical Medicine
Perelman School of Medicine
Ruth's Chris Steak House
1 Hilton Court
Parsippany, New Jersey 07054
ACCREDITATION AND CREDIT DESIGNATION STATEMENTS
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Practice Point Communications. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accredition Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide countinuing education for healthcare team.
The University of Nebraska Medical Center designates this live activity for a maximum of 1 AMA PRA Category 1 Credit (TM). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The New Jersey Association of Osteopathic Physicians and Surgeons is accredited by the American Osteopthic Association. NJAOPS designated this live activity for a maximum of 1.0 AOA Category 1-A CME Credits.
- Explain new diagnostic approaches in evaluating suspected PAH and monitoring patient progress as techniques become validated
- Assess the use of effective combination therapy strategies to integrate the latest clinical data into patient care in the setting of PAH
- List new therapeutics into the treatment paradigm for PAH as they become FDA approved, while avoiding off-label use of approaches not proven to be beneficial in PAH
- Describe new therapeutic clinical trials for patients with PAH
∙ All AMA credit must be issued through Practice Point Communications
∙ Each attendee must sign in the day of the lecture
∙ Each attendee must complete an evaluation whether applying for AMA credit or not.